Literature DB >> 9105852

Hydrolysis of imipenem, meropenem, ceftazidime, and cefepime by multiresistant nosocomial strains of Sphingobacterium multivorum.

J Blahová, K Králiková, V Krcméry, K Kubonová.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9105852     DOI： 10.1007/bf01709484

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  11 in total

1.  Cutaneous infection caused by Flavobacterium meningosepticum.

Authors:  R Bolivar; W Abramovits
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

2.  Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.

Authors:  D M Livermore; M Yuan
Journal:  J Antimicrob Chemother       Date:  1996-09       Impact factor: 5.790

3.  Bacteremic necrotizing fasciitis due to Flavobacterium odoratum.

Authors:  P R Hsueh; J J Wu; T R Hsiue; W C Hsieh
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

Review 4.  Metallo-beta-lactamases--a new therapeutic challenge.

Authors:  D J Payne
Journal:  J Med Microbiol       Date:  1993-08       Impact factor: 2.472

5.  Resistance to and hydrolysis of imipenem in nosocomial strains of Flavobacterium meningosepticum.

Authors:  J Blahová; M Hupková; V Krcméry; K Kubonová
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-10       Impact factor: 3.267

Review 6.  Taxonomy (and ecology) of Flavobacterium and related genera.

Authors:  J M Shewan; T A McMeekin
Journal:  Annu Rev Microbiol       Date:  1983       Impact factor: 15.500

7.  Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis.

Authors:  H S Sader; R N Jones; M A Pfaller
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

8.  Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.

Authors:  D Sirot; C Chanal; C Henquell; R Labia; J Sirot; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1994-06       Impact factor: 5.790

9.  In vitro antibacterial activity and beta-lactamase stability of SY5555, a new oral penem antibiotic.

Authors:  E Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

Review 10.  Origin and impact of plasmid-mediated extended-spectrum beta-lactamases.

Authors:  A Philippon; G Arlet; P H Lagrange
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267
View more
  5 in total

Review 1.  Meropenem: a review of its use in patients in intensive care.

Authors:  M Hurst; H M Lamb
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  Molecular characterization of membrane-associated soluble serine palmitoyltransferases from Sphingobacterium multivorum and Bdellovibrio stolpii.

Authors:  Hiroko Ikushiro; Mohammad Mainul Islam; Hiromasa Tojo; Hideyuki Hayashi
Journal:  J Bacteriol       Date:  2007-06-08       Impact factor: 3.490

3.  Septic arthritis by Sphingobacterium multivorum in imunocompromised pediatric patient.

Authors:  Maiana Darwich Mendes; Rafael Ruiz Cavallo; Cecilia Helena Vieira Franco Godoy Carvalhães; Maria Aparecida Gadiani Ferrarini
Journal:  Rev Paul Pediatr       Date:  2016-02-01

4.  Sphingobacterium multivorum: case report and literature review.

Authors:  F Barahona; J Slim
Journal:  New Microbes New Infect       Date:  2015-05-16

5.  Sphingobacterium spiritivorum bacteremia due to cellulitis in an elderly man with chronic obstructive pulmonary disease and congestive heart failure: a case report.

Authors:  Arata Hibi; Yuka Kumano
Journal:  J Med Case Rep       Date:  2017-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.